NCT00082914View on ClinicalTrials.gov

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2004

Study Completion Date

July 31, 2006

Conditions
Kidney CancerMelanoma (Skin)
Interventions
BIOLOGICAL

denileukin diftitox

Trial Locations (2)

20892

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00082914 - Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter